Clinical Molecular Diagnostics Laboratory

Ipsum Diagnostics is a CAP-accredited, CLIA certified, High Complexity national reference laboratory focused on providing exceptional clinical testing services. Ipsum’s Clinical Molecular Diagnostics Division provides unparalleled interpretation of polymicrobial infections. With expertise from nationally recognized Infectious Disease specialists, dermatologists, pathologists and molecular biologists, each case is personalized for rapid, optimal and cost-effective patient care.


Provide high quality, end-to-end solutions focusing on customized services to satisfy our clients’ specific needs.

Simplify the process of targeted testing to expedite treatment and best practice outcomes for each of our clients’ patients.

Executive Leadership Team

Our experienced technical team, accredited with CLIA High-Complexity Laboratory standards, include director Henry Skelton, MD, board-certified in anatomical and clinical pathology. With almost a century of combined experience our team has the know-how to ensure the highest quality of testing and results. In addition, if you need to confer with one of our Infectious Disease specialists and review your results simply call, email or use our mobile app.


Chief Executive Officer, Founding Partner


Founding Partner and Vice President of Business Development


Chief Operating Officer

Vivian Lee

Chief Financial Officer


Laboratory Medical Director


General Counsel

Lauren Spanjer

Co-Founder and Chief Executive Officer

Lauren Bricks is Co-Founder and Chief Executive Officer of Ipsum Diagnostics. She earned her B.S. in Biology and an M.B.A. from the University of Maryland. Lauren started Ipsum in 2016, and in 2018, she expanded the medical testing laboratory by launching its molecular department that focused on PCR testing for infectious organisms. Leveraging her technical and regulatory expertise, in early 2020, her team developed a COVID-19 PCR test that was granted Emergency Use Authorization by the FDA. Under her leadership, the company provided PCR testing throughout the state of Georgia through their partnership with the Georgia Department of Public Health. She was honored by Atlanta Magazine’s 2021 “Women Making a Mark” and recognized in Atlanta Business Chronicles’ “Forty Under 40.” Lauren was recently appointed to the Board of Directors for the Boys & Girls Club of Metro Atlanta. Lauren recently was featured on WSB-TV Channel 2 News (ABC affiliate) presenting Ipsum as the first independent laboratory in Georgia to offer Monkeypox testing.

Lauren is passionate about developing and providing innovative solutions that ensure Ipsum providers and patients receive accurate and fast test results that are directly accessible on a smartphone, tablet or computer portal. A primary focus of Lauren’s achievements is a program that addresses diagnostic testing for underserved populations. The most important thing for Lauren is that a patient’s health care information is easy to understand and sharable to support effective diagnosis and treatment and to guarantee the best outcomes for each patient. When Lauren is not working hard protecting the community, she is with her son and daughter either at a school event or at home with two dogs, one cat and one bearded dragon. In her free time, she likes practicing Krav Maga.

Colin Rogers

Co-Founder and Vice President of Business Development

Colin Rogers is Co-Founder of Ipsum Diagnostics, and presently operates in the role of Vice President of Business Development. Colin has over 20 years of experience as a sales professional, including over 15 years in the medical field. His knowledge and experience in medical sales allows him to positively navigate relationships with medical professionals and organizations of all specialties, and forging partnerships on behalf of Ipsum. Colin grew up in Danville, Kentucky, and attended Furman University on a full athletic scholarship, graduating with a B.A. in History. Colin lives with his wife Corinna and their two young children, Cash and Carson. Colin’s personal interests include traveling, hiking, and spending as much time as possible with his family.

Leah Roberts

Chief Operating Officer

Leah Roberts, MPH, MB(ASCP) CM , is the Chief Operating Officer for Ipsum Diagnostics. Leah is a board-certified molecular biologist and a Lean Six-Sigma certified green belt. Leah has a B.S. in Biology from Wesleyan College and a Master of Public Health from Walden University. In December 2019, just as COVID-19 was emerging, Leah joined Ipsum as a Molecular Technologist. Demonstrating her sense of organizational and management skills, Leah was promoted to Molecular Diagnostic Manager, and subsequently named Chief Operating Officer in 2021. During the height of the U.S. COVID-19 outbreak, Leah was instrumental in guiding Ipsum’s effort to develop a high-throughput COVID-19 test to process as many samples as possible while maintaining the highest standards for rapid and accurate test results. Ipsum became the first laboratory in Georgia to be granted Emergency Use Authorization by FDA for this process. Some of Leah’s achievements include receiving the “Wesleyan College Young Alumna Award,” and being an honoree at the “2022 ASCP 40 Under Forty” along with the “2022 Women of the Year in Steam”, where Leah was one of the top three finalists for the “Women in Science” category.

Leah’s passion is helping to address the needs of underserved populations and paving the way for females and minorities in the sciences.

Vivian Lee

Chief Financial Officer

Vivian Lee is the Chief Financial Officer of Ipsum Diagnostics, leading the company's efforts around financial operations, planning, budgeting, and forecasting. She is an experienced financial executive, with over 20 years of experience in Finance, Operations and Internal Audit in global Fortune 500 and privately owned companies. Vivian attended both Iowa Wesleyan College and the University of Phoenix. She has her B.A. in Accounting and a Master of Business Administration in Global Management. Vivian is also a Certified Public Accountant, and Certified Internal Auditor. She enjoys reading, and vacationing in Florida with her husband and their two rescue dogs.

Dr. Henry Skelton

Laboratory Director

As the Laboratory Director, Dr. Henry Skelton ensures that Ipsum’s lab services are administered according to established rules, regulations and standards. He is board certified in anatomic and clinical pathology, and Dermatopathology and has practiced Dermatopathology for over 25 years. Dr. Skelton completed a general internship and then a residency in anatomic and clinical pathology at the Naval Hospital Portsmouth, Virginia. After completing his residency, he served as head of both cytology and anatomic pathology at the same hospital. He did his dermatopathology fellowship at the Armed Forces Institute of Pathology and became a consulting dermatopathologist that included teaching staff at this same Institute. Dr. Skelton moved on to the University of Alabama at Birmingham where he was professor of Pathology and served as co-director of the dermatopathology fellowship program. He is author or co-author of over 150 peer reviewed publications and has frequently lectured at local and national medical meetings. For the last 15 years he has concentrated full time in dermatopathology diagnosis. Outside of his professional career, he enjoys the art of woodworking that provides him with challenging projects and creative hand-made treasures he can enjoy for years to come.

Elan Spanjer

General Counsel

Elan Spanjer has served as General Counsel of Ipsum Diagnostics since 2020. In this role, he advises the company’s management in various matters related to business partnerships and legal and regulatory compliance. Prior to joining Ipsum, Elan was an associate at a top-tier international law firm in New York City, where he advised clients on several multibillion-dollar M&A deals. Prior to entering the legal field, Elan worked as a financial services consultant for a large US-based consulting firm, where he performed risk modeling, analysis and stress testing and advised on merger integration for several large North American banks. Elan holds a B.A. in Economics and Mathematics from Yale University and a J.D. from Northwestern Pritzker School of Law. He is an avid runner, having completed four marathons. He also enjoys traveling, practicing Spanish, and spending time with his partner and their French bulldog.